Supriya Lifescience lists 55% higher over issue price; buy, sell or hold?

The IPO had received a strong response, which was subscribed 71.51 times on back of robust subscription of individual investors

Supriya Lifescience (SLL) has made a strong market debut, with its shares listing at Rs 425, a 55 per cent premium over its issue price of Rs 274 per share on the BSE. The stock has opened at Rs 421, a 54 per cent higher against its issue price on the National Stock Exchange (NSE).

At 10:01 am; the stock traded at Rs 396.80, 45 per cent higher to its issue price. It hit a low of Rs 388.25 on the BSE and a low of Rs 388 on the NSE in intra-day trade. A combined around 8.4 million